Literature DB >> 12044863

Progression of dystrophic features and activation of mitogen-activated protein kinases and calcineurin by physical exercise, in hearts of mdx mice.

Akinori Nakamura1, Kunihiro Yoshida, Shin'ichi Takeda, Naoko Dohi, Shu-ichi Ikeda.   

Abstract

We have previously demonstrated that calcineurin and p38 mitogen-activated protein kinase (MAPK) are up-regulated in the hearts of mdx mice. However, the degree of up-regulation observed was variable, which may reflect variable levels of daily physical activities among the mice. To investigate whether or not exercise affects dystrophic features and activates intracellular signaling molecules in mdx hearts, we subjected mdx and C57BL/10 mice to treadmill exercise and examined intracellular signaling molecules in cardiac muscles, at the protein level. The heart to body weight ratio was significantly increased in exercised mdx mice. Histopathology in exercised mdx hearts showed extensive infiltration of inflammatory cells, together with increases in interstitial fibrosis and adipose tissues, all of which were not observed either in exercised C57BL/10 or non-exercised mdx hearts. Phosphorylated p38 MAPK, phosphorylated extracellular signal-regulated kinase 1/2 and calcineurin, but not phosphorylated c-Jun N-terminal kinase 1, were up-regulated in exercised mdx hearts compared to exercised C57BL/10 or non-exercised mdx hearts. These data suggest that physical exercise accelerates the dystrophic process through activation of intracellular signaling molecules in dystrophin-deficient hearts.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12044863     DOI: 10.1016/s0014-5793(02)02739-4

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  38 in total

Review 1.  Cardiovascular Adaptations Induced by Resistance Training in Animal Models.

Authors:  S F S Melo; N D da Silva Júnior; V G Barauna; E M Oliveira
Journal:  Int J Med Sci       Date:  2018-02-12       Impact factor: 3.738

2.  Activated calcineurin ameliorates contraction-induced injury to skeletal muscles of mdx dystrophic mice.

Authors:  Nicole Stupka; David R Plant; Jonathan D Schertzer; Tennent M Emerson; Rhonda Bassel-Duby; Eric N Olson; Gordon S Lynch
Journal:  J Physiol       Date:  2006-06-22       Impact factor: 5.182

3.  Matrix metalloproteinase inhibitor batimastat alleviates pathology and improves skeletal muscle function in dystrophin-deficient mdx mice.

Authors:  Akhilesh Kumar; Shephali Bhatnagar; Ashok Kumar
Journal:  Am J Pathol       Date:  2010-05-14       Impact factor: 4.307

4.  Osteopontin-stimulated expression of matrix metalloproteinase-9 causes cardiomyopathy in the mdx model of Duchenne muscular dystrophy.

Authors:  Saurabh Dahiya; Srikanth Givvimani; Shephali Bhatnagar; Natia Qipshidze; Suresh C Tyagi; Ashok Kumar
Journal:  J Immunol       Date:  2011-08-01       Impact factor: 5.422

5.  Cytoplasmic gamma-actin contributes to a compensatory remodeling response in dystrophin-deficient muscle.

Authors:  Laurin M Hanft; Inna N Rybakova; Jitandrakumar R Patel; Jill A Rafael-Fortney; James M Ervasti
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-24       Impact factor: 11.205

6.  Adeno-associated virus serotype-9 microdystrophin gene therapy ameliorates electrocardiographic abnormalities in mdx mice.

Authors:  Brian Bostick; Yongping Yue; Yi Lai; Chun Long; Dejia Li; Dongsheng Duan
Journal:  Hum Gene Ther       Date:  2008-08       Impact factor: 5.695

7.  Proteomic Profiling of the Dystrophin-Deficient MDX Heart Reveals Drastically Altered Levels of Key Metabolic and Contractile Proteins.

Authors:  Caroline Lewis; Harald Jockusch; Kay Ohlendieck
Journal:  J Biomed Biotechnol       Date:  2010-05-23

8.  Sex modifies exercise and cardiac adaptation in mice.

Authors:  John P Konhilas; Alexander H Maass; Stephen W Luckey; Brian L Stauffer; Eric N Olson; Leslie A Leinwand
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-08-19       Impact factor: 4.733

Review 9.  Alterations in mitochondrial function as a harbinger of cardiomyopathy: lessons from the dystrophic heart.

Authors:  Yan Burelle; Maya Khairallah; Alexis Ascah; Bruce G Allen; Christian F Deschepper; Basil J Petrof; Christine Des Rosiers
Journal:  J Mol Cell Cardiol       Date:  2009-09-18       Impact factor: 5.000

10.  Phosphoinositide 3-kinase(p110alpha) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy.

Authors:  Julie R McMullen; Tetsuo Shioi; Li Zhang; Oleg Tarnavski; Megan C Sherwood; Peter M Kang; Seigo Izumo
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.